CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 45.60
  • +4.18+10.09%
Market Closed Jul 22 15:00 CST
4.38BMarket Cap27.92P/E (TTM)

R&G PharmaStudies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

R&G PharmaStudies Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

177.33M

+10.19%
EPS(YoY)

0.24

-50.00%
Analyst Rating

Strong Buy

Jul 22, 2024

R&G PharmaStudies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.041B--
--2024/FY-- / 865.307M--
--2023/FY721.373M / 770.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.041B--
--2024/FY-- / 865.307M--
--2023/FY721.373M / 770.000M--
--------
--------

Unlock Free Earnings Estimates

R&G PharmaStudies Earnings Reports

  • Norske: Annual Report 2023

    Apr 21 12:00 ET

  • Norsk: First quarter report 2024

    Apr 21 12:00 ET

  • Norsk: 2023 Annual Report Summary

    Apr 21 12:00 ET

  • Northcog: 2023 performance forecast

    Jan 29 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg